PL337725A1 - Inhibitors of proteases - Google Patents
Inhibitors of proteasesInfo
- Publication number
- PL337725A1 PL337725A1 PL98337725A PL33772598A PL337725A1 PL 337725 A1 PL337725 A1 PL 337725A1 PL 98337725 A PL98337725 A PL 98337725A PL 33772598 A PL33772598 A PL 33772598A PL 337725 A1 PL337725 A1 PL 337725A1
- Authority
- PL
- Poland
- Prior art keywords
- proteases
- inhibitors
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06139—Dipeptides with the first amino acid being heterocyclic
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US4506797P | 1997-04-29 | 1997-04-29 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL337725A1 true PL337725A1 (en) | 2000-08-28 |
Family
ID=21935831
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL98337725A PL337725A1 (en) | 1997-04-29 | 1998-04-29 | Inhibitors of proteases |
Country Status (18)
| Country | Link |
|---|---|
| EP (1) | EP1019046A4 (ko) |
| JP (1) | JP2002504097A (ko) |
| KR (1) | KR20010020391A (ko) |
| CN (1) | CN1261276A (ko) |
| AR (1) | AR012622A1 (ko) |
| AU (1) | AU7365198A (ko) |
| BR (1) | BR9809333A (ko) |
| CA (1) | CA2287989A1 (ko) |
| CO (1) | CO4940477A1 (ko) |
| HU (1) | HUP0001294A3 (ko) |
| IL (1) | IL132629A0 (ko) |
| MA (1) | MA26487A1 (ko) |
| NO (1) | NO995268L (ko) |
| PE (1) | PE69099A1 (ko) |
| PL (1) | PL337725A1 (ko) |
| TR (1) | TR199902703T2 (ko) |
| WO (1) | WO1998048799A1 (ko) |
| ZA (1) | ZA983522B (ko) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1999032121A1 (en) | 1997-12-19 | 1999-07-01 | Smithkline Beecham Corporation | Compounds of heteroaryl substituted imidazole, their pharmaceutical compositions and uses |
| US6100282A (en) * | 1998-01-02 | 2000-08-08 | Hoffman-La Roche Inc. | Thiazole derivatives |
| MA26618A1 (fr) * | 1998-04-09 | 2004-12-20 | Smithkline Beecham Corp | Composes et compositions pharmaceutiques pour le traitement du paludisme |
| US6858617B2 (en) | 1998-05-26 | 2005-02-22 | Smithkline Beecham Corporation | Substituted imidazole compounds |
| EP1126852B1 (en) | 1998-11-04 | 2004-01-21 | SmithKline Beecham Corporation | Pyridin-4-yl or pyrimidin-4-yl substituted pyrazines |
| CO5150165A1 (es) * | 1998-11-13 | 2002-04-29 | Smithkline Beecham Plc | Inhibidores de proteasa: tipo catepsina k |
| US20030144175A1 (en) | 1998-12-23 | 2003-07-31 | Smithkline Beecham Corporation | Protease inhibitors |
| EP1232154A4 (en) | 1999-11-10 | 2004-06-23 | Smithkline Beecham Corp | PROTEASE INHIBITORS |
| EP1232155A4 (en) | 1999-11-10 | 2002-11-20 | Smithkline Beecham Corp | PROTEASE INHIBITORS |
| US6534498B1 (en) | 1999-11-10 | 2003-03-18 | Smithkline Beecham Corporation | Protease inhibitors |
| US6797720B2 (en) | 1999-12-03 | 2004-09-28 | Ono Pharmaceutical Co., Ltd. | 1,3,4-oxadiazoline derivative and an agent comprising its derivative as active ingredient |
| EP1234821A4 (en) * | 1999-12-03 | 2002-10-28 | Ono Pharmaceutical Co | 1,3,4-OXADIAZOLINE DERIVATIVES AND MEDICINES THAT CONTAIN THEIR ACTIVE SUBSTANCE |
| CN1416346A (zh) | 2000-03-21 | 2003-05-07 | 史密丝克莱恩比彻姆公司 | 蛋白酶抑制剂 |
| EP1465862A1 (en) | 2002-01-17 | 2004-10-13 | SmithKline Beecham Corporation | Cycloalkyl ketoamides derivatives useful as cathepsin k inhibitors |
| MXPA04011363A (es) * | 2002-07-04 | 2005-02-14 | Aventis Pharma Sa | Nuevos derivados acil hidrazino del tiofeno, su procedimiento de preparacion, su aplicacion como medicamentos, composiciones farmaceuticas y nueva utilizacion. |
| KR100962972B1 (ko) | 2002-07-26 | 2010-06-09 | 주식회사유한양행 | 1-페닐피페리딘-3-온 유도체 및 그의 제조방법 |
| WO2011015524A2 (en) * | 2009-08-03 | 2011-02-10 | Bayer Cropscience Ag | Fungicide heterocycles derivatives |
| ES2779748T3 (es) * | 2012-08-23 | 2020-08-19 | Janssen Biopharma Inc | Compuestos para el tratamiento de infecciones víricas por paramixovirus |
| JP6485817B2 (ja) | 2013-08-21 | 2019-03-20 | ヤンセン バイオファーマ インク． | 抗ウイルス化合物 |
| MA41614A (fr) | 2015-02-25 | 2018-01-02 | Alios Biopharma Inc | Composés antiviraux |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0934291A1 (en) * | 1995-10-30 | 1999-08-11 | Smithkline Beecham Corporation | Protease inhibitors |
-
1998
- 1998-04-24 MA MA25047A patent/MA26487A1/fr unknown
- 1998-04-27 PE PE1998000320A patent/PE69099A1/es not_active Application Discontinuation
- 1998-04-28 ZA ZA983522A patent/ZA983522B/xx unknown
- 1998-04-29 PL PL98337725A patent/PL337725A1/xx unknown
- 1998-04-29 CN CN98806641A patent/CN1261276A/zh active Pending
- 1998-04-29 EP EP98920926A patent/EP1019046A4/en not_active Withdrawn
- 1998-04-29 KR KR1019997010013A patent/KR20010020391A/ko not_active Application Discontinuation
- 1998-04-29 HU HU0001294A patent/HUP0001294A3/hu unknown
- 1998-04-29 IL IL13262998A patent/IL132629A0/xx unknown
- 1998-04-29 JP JP54738998A patent/JP2002504097A/ja active Pending
- 1998-04-29 CO CO98023491A patent/CO4940477A1/es unknown
- 1998-04-29 BR BR9809333-9A patent/BR9809333A/pt not_active IP Right Cessation
- 1998-04-29 TR TR1999/02703T patent/TR199902703T2/xx unknown
- 1998-04-29 WO PCT/US1998/008740 patent/WO1998048799A1/en not_active Application Discontinuation
- 1998-04-29 CA CA002287989A patent/CA2287989A1/en not_active Abandoned
- 1998-04-29 AR ARP980101999A patent/AR012622A1/es unknown
- 1998-04-29 AU AU73651/98A patent/AU7365198A/en not_active Abandoned
-
1999
- 1999-10-28 NO NO995268A patent/NO995268L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CO4940477A1 (es) | 2000-07-24 |
| CA2287989A1 (en) | 1998-11-05 |
| JP2002504097A (ja) | 2002-02-05 |
| AU7365198A (en) | 1998-11-24 |
| HUP0001294A3 (en) | 2001-06-28 |
| NO995268D0 (no) | 1999-10-28 |
| WO1998048799A1 (en) | 1998-11-05 |
| EP1019046A4 (en) | 2002-11-27 |
| ZA983522B (en) | 1998-10-29 |
| PE69099A1 (es) | 1999-09-26 |
| MA26487A1 (fr) | 2004-12-20 |
| KR20010020391A (ko) | 2001-03-15 |
| NO995268L (no) | 1999-11-15 |
| EP1019046A1 (en) | 2000-07-19 |
| CN1261276A (zh) | 2000-07-26 |
| TR199902703T2 (xx) | 2000-02-21 |
| BR9809333A (pt) | 2000-07-04 |
| AR012622A1 (es) | 2000-11-08 |
| HUP0001294A2 (hu) | 2001-04-28 |
| IL132629A0 (en) | 2001-03-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AP9701054A0 (en) | Inhibitors of cycteine protease | |
| PL341762A1 (en) | Precursors of aspartil protease inhibitors | |
| IL131661A0 (en) | Protease inhibitors | |
| PL334846A1 (en) | Sulphamidic inhibitors of metaloproteases | |
| PL336589A1 (en) | Serinic protease inhibitors | |
| EP1009415A4 (en) | INHIBITORS OF $ g (b) -LACTAMASES AND THEIR USES | |
| PL323710A1 (en) | Reversible inhibitors of cysteinic protease | |
| PL326508A1 (en) | Protease inhibitors | |
| PL333505A1 (en) | Benzamido-aldehydes and their application as inhibitors of cysteinic proteases | |
| PL339738A1 (en) | Novel lactamic inhibitors of metaloproteinases | |
| PL337725A1 (en) | Inhibitors of proteases | |
| PL328307A1 (en) | Serinic protease inhibitors | |
| HU0900792D0 (en) | Use of renin-angiotensin inhibitors | |
| HUP0002247A3 (en) | Protease inhibitors | |
| PL328665A1 (en) | Inhibitors of serinic protease | |
| EP0923535A4 (en) | CYSTEINE PROTEASE INHIBITORS | |
| IL132630A0 (en) | Protease inhibitors | |
| PL334975A1 (en) | Application of gasto-intestinal lipase inhibitors | |
| ZA988479B (en) | Protease inhibitors | |
| PL328875A1 (en) | Serinic protease inhibitors | |
| PL328223A1 (en) | Aspartil protease inhibitors | |
| HUP0101640A3 (en) | Certain thoil inhibitors of endothelin-converting enzyme | |
| ZA983065B (en) | Inhibitors of protein farnesyltranferase | |
| ZA988064B (en) | Protease inhibitors | |
| EP0975612A4 (en) | PROTEASE INHIBITORS |